AzTrials
AzTrials

Fragile X SyndromeNCT04610424

Cooperative Parent Mediated Therapy in Children With Fragile X Syndrome and Williams Syndrome

A study testing Cooperative Parent Mediated Therapy" (CPMT) and As usual in people with Fragile X Syndrome and Williams Syndrome, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Fragile X Syndrome (FXS) and Williams-Beuren Syndrome (WBS) are relatively rare disorders characterized by developmental delay associated to socio-communicative deficit and autistic-like behaviours. WBS has been considered for a long time as the "polar opposite" of ASD, given their hypersociable phenotype. Read more about this study

Who is it for?
Ages 1 year to 7 years
Conditions the study is for
Fragile X Syndrome, Williams Syndrome
What is being tested?
Cooperative Parent Mediated Therapy" (CPMT) and As usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteItaly
Study dates
17 May 2017to Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Molecularly confirmed diagnosis of Fragile X Syndrome
  • Molecularly confirmed diagnosis of Williams-Beuren Syndrome
  • Autism features
  • Score > or = 4 in Clinical Global Impression (Guy et al., 1976)

Who cannot join

  • Parent yet enrolled in a parent training during first evaluation

Trial locations and contacts

1 site in 1 country.

Paolo Alfieri, PhD, MD contact

0668594721

paolo.alfieri@opbg.net

Italy1 site, 1 recruiting
  • Ospedale Pediatrico Bambino Gesù

    Roma, 00146

    Paolo Alfieri, MD-PhD, 0668594721, paolo.alfieri@opbg.net

    Recruiting

Other trials in Italy

About this study

Fragile X Syndrome (FXS) and Williams-Beuren Syndrome (WBS) are relatively rare disorders characterized by developmental delay associated to socio-communicative deficit and autistic-like behaviours.

WBS has been considered for a long time as the "polar opposite" of ASD, given their hypersociable phenotype. Nonetheless, recent researches have emphasized similarities between ASD and WBS phenotypes. By following some authors "social abnormalities in ASD and WS can be characterized in terms of analogous difficulties in social cognition), and distinct patterns of social motivation which appears to be reduced in ASD and enhanced in WBS". More than opposite condition, these authors suggests that WBS and ASD could share the same difficult in comprehension of social relationship, with opposite pattern of social engagement (enhanced in WBS and weakened ASD). Given, these similarities authors suggest testing the feasibility and validity of therapy for ASD in children with WBS. Parent Mediated Therapy (PMT) is a group of "technique-focused interventions where the parent is the agent of change and the child is the direct beneficiary of treatment". PMT demonstrated evidence of effectiveness in socio-communicational improvement for children with ASD in a randomized controlled trial (RCT).

Read more

Some recent researchers have extended the use of PMT to children with genetic disorders and autistic features, such as FXS. While showing encouraging results, the samples of research were limited.

They main aim of this research is to to verify effectiveness of Cooperative PMT (CMPT) for socio-communicative deficit in children with FXS and WBS. Our hypothesis is that CPMT, in addition to conventional rehabilitation therapies (mainly speech therapy and occupational therapies), could contribute to the enhancement of socio-communicative skills and the reduction of behavioural problems. We also expected also an improvement in family quality of life and a reduction of parental stress.

Read the detailed description

Fragile X Syndrome (FXS) and Williams-Beuren Syndrome (WBS) are relatively rare disorders characterized by developmental delay associated to socio-communicative deficit and autistic-like behaviours. FXS is one of the most common monogenetic cause of syndromic Autism Spectrum Disorder (ASD); up to 60% of males with FXS meet criteria for ASD. Furthermore, around 30%- 35% of children with WBS meet criteria for ASD. WBS has been considered for a long time as the "polar opposite" of ASD, given their hypersociable phenotype and their abnormal interest in social engagement. Nonetheless, recent researches have emphasized similarities between ASD and WBS phenotypes. By following Vivanti "social abnormalities in ASD and WS can be characterized in terms of analogous difficulties in social cognition (the ability to read others' behaviour), and distinct patterns of social motivation (the propensity for social approach/engagement) which appears to be reduced in ASD and enhanced in WS". More than opposite condition, VIvanti suggests that WBS and ASD could share the same difficult in comprehension of social relationship, with opposite pattern of social engagement (enhanced in WBS and weakened ASD). Moreover, some researches showed that children with WS were similarly delayed in global adaptive functioning when compared to ones with ASD. Given, these similarities authors suggest to test the feasibility and validity of therapy for ASD in children with WBS. Parent Mediated Therapy (PMT) is a group of "technique-focused interventions where the parent is the agent of change and the child is the direct beneficiary of treatment". Italian Guidelines for ASD highlight the importance of PMT for ASD treatment. PMT is also strongly recommended by NICE Clinical Guideline CG170 and WHO Mental Health Gap Action Program. PMT has showed evidence of effectiveness in short and long-term symptom reduction in young children with ASD. A research project on the effectiveness of PMT for children with ASD has been activated since 10 years at the Bambino Gesù Children Hospital (BGCH) in Rome. In last years, a semi-manualized intervention called "Cooperative Parent Mediated Therapy" (CPMT) has been systematized. Following Bearss' Parent Training taxonomy, CPMT is a targeted parent-mediated intervention focused on the ASD core symptoms. CPMT is based on the most significant models of parent training for ASD, in the perspective of Naturalistic Developmental Behavioral Interventions-NDBI with specific attention to the promotion of cooperative interactions. The aim of CPMT is to improve parental skills, to enable parents promoting the following seven target skills in their child: socio-emotional engagement, emotional regulation, imitation, communication, joint attention, play and cognitive flexibility and cooperative interaction. An individualized treatment plan is designed for each child in order to determine his developmental level and treatment goals. CMPT usually last 6 months, for a total amount of 15 sessions of 90 min; twelve core sessions (one session per week) are delivered in the first 3 months, followed by 3 monthly booster sessions. Each weekly core session had a specific focus and specific intervention strategies based on active parent coaching during parent-child interaction, and included the parent-child dyad with the parent being actively coached by a trained therapist. Live active coaching increases parents' competence in implementing strategies to enhance child development, and at the same time increases their confidence. This intervention has demonstrated evidence of effectiveness in socio-communicational improvement as measured by ADOS-G in a randomized controlled trial (RCT). On this purpose, some recent researchers have extended the use of PMT to children with genetic disorders and autistic features, such as Fragile X Syndrome (Vismara et al., 2019). While showing encouraging results, the samples of research were limited (four participants); moreover, parent coaching took place mainly through digital services (e.g. video call). Authors suggest implementing RCTs with larger samples in order to evaluate validity of PMT for individuals with FXS. Moreover, as far as we know, there are currently no researches of PMT in patients with WBS.

Since 2017, an experimental, non-pharmacological, randomized, controlled monocentric and non-profit study was started at BGCH in order to verify effectiveness of CPMT for socio-communicative deficit in children with FXS and WBS. Our hypothesis is that CPMT, in addition to conventional rehabilitation therapies (mainly speech therapy and occupational therapies), could contribute to the enhancement of socio-communicative skills and the reduction of behavioural problems. We also expected also an improvement in family quality of life and a reduction of parental stress. The intervention is provided by psychologists with specific training and expertise in CPMT and monitored through supervision by a senior child psychiatrist

Assessment: Children and their family will be evaluated at two time-points, pre randomization (T0) and six months later, at the end of control/treatment period (T1), by means of following assessment tools :

Children: 1. Cognitive Level: Leiter 3/Griffiths III; appropriate tool will be used by evaluation of developmental level 2. Adaptive Level: Vineland Adaptive Behavior Scales, Second Edition; 3. Socio-communication skills: Early Social Communication Scales; the questionnaire Skills Socio-Conversational of the Child (Le abilità socio-conversazionali del bambino; ASCB) ; 4. Language level: Italian adaptation of "MacArthur-Bates Communicative Development Inventories". - Il Primo Vocabolario del Bambino; 5. Behavioural problem: Child Behavior Checklist; 6. Clinical improvement: Clinical Global Impression - Severity scale; Clinical Global Impression - Improvement scale

Parents: 1. Parental Stress: Parenting Stress Index-Short Form; 2. Parental Quality of Life: WHO Quality of Life

Being tested
Cooperative Parent Mediated Therapy" (CPMT), As usual
Medical subject headings
Fragile X Syndrome, Williams Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cooperative Parent Mediated Therapy" (CPMT)Behavioural

    CMPT usually last 6 months, for a total amount of 15 sessions of 90 min; twelve core sessions (one session per week) are delivered in the first 3 months, followed by 3 monthly booster sessions. Each weekly core session had a specific focus and specific intervention strategies based on active parent coaching during parent-child interaction, and included the parent-child dyad with the parent being actively coached by a trained therapist. Live active coaching increases parents' competence in implementing strategies to enhance child development, and at the same time increases their confidence. This intervention has demonstrated evidence of effectiveness in socio-communicational improvement as measured by ADOS-G (Valeri, 2019) in a randomized controlled trial (RCT).

  • As usualBehavioural

    Speech Language Therapy and Occuapational Therapy provided as usual by National Health Services

Study groups in NCT04610424
Study groupRoleWhat they receive
Cooperative Parent Mediated TherapyExperimentalCooperative Parent Mediated Therapy" (CPMT) is a targeted parent-mediated intervention focused on the ASD core symptoms (Bearss et al., 2015). CPMT is based on the most significant models of parent training for ASD, in the perspective of Naturalistic Developmental Behavioral Interventions-NDBI with specific attention to the promotion of cooperative interactions (Schreibman et al., 2016). The aim of CPMT is to improve parental skills, to enable parents promoting the following seven target skills in their child: socio-emotional engagement, emotional regulation, imitation, communication, joint attention, play and cognitive flexibility and cooperative interaction. An individualized treatment plan is designed for each child in order to determine his developmental level and treatment goals (Valeri et al., 2019).
Receives: Behavioral: Cooperative Parent Mediated Therapy" (CPMT); Behavioral: As usual
ControlActive comparatorControl group
Receives: Behavioral: As usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Joint attention

    Joint attention score from ESCS assessment. Score expressed in percentage of behavior/number of occasion (from 0% to 100%). Higher scores indicate better functioning

    Measured: 6 months

  2. Assertivity

    Assertivity as measured by Skills Socio-Conversational of the Child. Scores from 1 to 5 (Higher scores indicate better functioning)

    Measured: 6 months

  3. Responsivity

    Assertivity as measured by Skills Socio-Conversational of the Child. Scores from 1 to 5 (Higher scores indicate better functioning)

    Measured: 6 months

  4. Expressive language (Word)

    Expressive language as measured by word production scale of Primo vocabolario del bambino (from 0 to 408). higher raw scores indicate higher level of language

    Measured: 6 months

  5. Expressive language (Gestures)

    Expressive language as measured by gestures production scale of Primo vocabolario del bambino (from 0 to 63). higher raw scores indicate higher level of language

    Measured: 6 months

  6. Receptive Language (Word)

    Receptive language as measured word comprehension scale of Primo vocabolario del bambino (from 0 to 408). higher raw scores indicate higher level of language

    Measured: 6 months

  7. Receptive Language (Sentences)

    Receptive language as measured by sentence comprehension scale of Primo vocabolario del bambino (from 0 to 28). higher raw scores indicate higher level of language

    Measured: 6 months

Secondary outcomes (13)
  1. Behavioral and emotional problem

    Behavioral and emotional problems as measurd by Child Behavior Checklist (T-scores, Mean 50, standard deviation 15). Higher scores indicate severe problems. >64 borderline >70 clinical

    Measured: 6 months

  2. Change in Adaptive Level (Vineland Adaptive Behavior Scales, Second Edition)

    Adaptive functioning of children. Scores are expressed in standard scores (mean 100, Standard deviation 15). Higher scores indicate better functioning.

    Measured: 6 months

  3. Clinical improvement: Clinical Global Impression - Severity scale

    Clinical Global Impression - Severity scale is a 7-point scale used to measure baseline severity of patients (Higher scores indicate more severe patient.

    Measured: 6 months

  4. Clinical Global Impression - Improvement scale (CGI-I)

    Clinical Global Impression - Improvement scale (CGI-I) s a 7-point scale used to measure improvement after treatment (Higher scores indicate more severe symptoms)

    Measured: 6 months

  5. Cognitive/developmental Level

    Developmental/cognitive level of children as measured by Leiter 3 /Griffiths III. Scores are expressed in standard scores (mean 100, Standard deviation 15). Higher scores indicate better functioning

    Measured: 6 months

  6. Quality of Life (Social Relationship) of parents

    Quality of life (Social Relationship) as measured by (WHOQOL). Scores are expressed in raw scores from 0 to 100 (higher scores indicate better quality of life.

    Measured: 6 momths

  7. Quality of Life (Environmental) of parents

    Quality of life (Environmental) as measured by (WHOQOL). Scores are expressed in raw scores from 0 to 100 (higher scores indicate better quality of life.

    Measured: 6 momths

  8. Quality of Life (Fisical) of parents

    Quality of life (Fisical) as measured by (WHOQOL). Scores are expressed in raw scores from 0 to 100 (higher scores indicate better quality of life.

    Measured: 6 momths

  9. Quality of Life (Psychological) of parents

    Quality of life (Psychological) as measured by (WHOQOL). Scores are expressed in raw scores from 0 to 100 (higher scores indicate better quality of life.

    Measured: 6 momths

  10. Change in Parenting Stress (Parental Distress)

    Parenting Stress as measured by Parendal Distress Scale of Parenting Stress Index Short Form. Scores are expressed in percentile (from 5° to 100°). Higher scores indicate higher level of stress

    Measured: 6 months

  11. Change in Parenting Stress (Difficult Child)

    Parenting Stress as measured by Difficult Child Scale of Parenting Stress Index Short Form. Scores are expressed in percentile (from 5° to 100°). Higher scores indicate higher level of stress

    Measured: 6 months

  12. Change in Parenting Stress (Parent-Child Dysfunctional Interaction)

    Parenting Stress as measured by Parent-Child Dysfunctional Interaction Scale of Parenting Stress Index Short Form. Scores are expressed in percentile (from 5° to 100°). Higher scores indicate higher level of stress

    Measured: 6 months

  13. Change in Parenting Stress (Total Score)

    Parenting Stress as measured by Total Stress Scale of Parenting Stress Index Short Form. Scores are expressed in percentile (from 5° to 100°). Higher scores indicate higher level of stress

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2020
  2. Study start17 May 2017
  3. Primary completionJun 2021 (estimated)
  4. Study completionJun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
14 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04610424
Sponsor's protocol ID
1324_OPBG_2017
Status last verified
Oct 2020
First submitted
8 Oct 2020
Last updated
30 Oct 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cooperative Parent Mediated Therapy" (CPMT) and As usual in people with Fragile X Syndrome and Williams Syndrome, run by Bambino Gesù Hospital and Research Institute at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paolo Alfieri, PhD, MD (0668594721, paolo.alfieri@opbg.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Joint attention (time frame: 6 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in